Riskpilot← Back to searchSign inGet full accessNaprapat Berglund AB
ABActiveOrg 5590190046Residensgatan 1 APhysiotherapy activities · NACE 8695Est. 20150 employees
Revenue 2025
SEK 0
EBITDA margin
—
-318% vs 2024
Equity ratio
74.9%
Financial strength
Net profit 2025
SEK 11K
-49% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -6K | -318% |
| Net profit | SEK 11K | -49% |
| Total assets | SEK 1,4M | -2% |
| Equity | SEK 1M | +1% |
| Employees | 0 | — |
Legal name
Naprapat Berglund AB
Org number
5590190046
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
1 juli 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva verksamhet huvudsakligen inom naprapati det vill säga naprapatbehandlingar och rehabiliterande träning samt viss försäljning av terapeutisk rehabutrustning och produkter. Vidare kommer bolaget att till viss del bedriva föreläsningar inom medicinska ämnen, samt därmed förenlig verksamhet.
Address
Residensgatan 1 A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | −0 | 0 | 0 |
| Staff expenses | — | −60 | −1 | 2 | −1 |
| EBITDA | −1 346 | −37 | 73 | 3 | −6 |
| Depreciation & amort. | −10 | −10 | −10 | −10 | −7 |
| EBIT | −1 356 | −46 | 63 | −7 | −13 |
| Net financials | 1 786 | 1 330 | −41 | 50 | −1 |
| Profit before tax | 430 | 960 | 15 | 29 | 15 |
| Tax | −89 | −200 | −4 | −9 | −5 |
| Net profit | 341 | 760 | 11 | 21 | 11 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 572 | 3 186 | 1 616 | 1 386 | 1 364 |
| Equity | 1 375 | 1 655 | 990 | 1 011 | 1 022 |
| Long-term debt | 1 055 | 1 086 | 205 | 17 | 17 |
| Short-term debt | 142 | 122 | 90 | 13 | 10 |
| Total debt | 1 197 | 1 208 | 295 | 30 | 27 |
EBITDA margin
-581800.0%
This company
15.8%
Market median
-3682378% vs market
20212025
Equity ratio
74.9%
This company
38.2%
Market median
+96% vs market
20212025
Return on equity
1.0%
This company
18.4%
Market median
-95% vs market
20212025
Net profit margin
1070100.0%
This company
8.1%
Market median
+13211011% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Naprapat Berglund AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristofer Viktor Berglund | Deputy Board Member | 0 companies |
| Rolf Oskar Berglund | Board of Directors | 0 companies |